Overview

Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)

Status:
Recruiting
Trial end date:
2021-04-30
Target enrollment:
Participant gender:
Summary
This is a study evaluating the usage of Ketamine as sedative agent in ERCP. The usage of Ketamine will be compared to the standard sedation in our center, which is Midazolam in combination with Pethidine as analgesia.
Phase:
Phase 4
Details
Lead Sponsor:
Universiti Kebangsaan Malaysia Medical Centre
Treatments:
Ketamine